Joe Bonaccorso
Corporate Officer/Principal bij VERRICA PHARMACEUTICALS INC.
Vermogen: 783 761 $ op 31-03-2024
Profiel
Joe Bonaccorso is currently the Chief Commercial Officer at Verrica Pharmaceuticals, Inc. He previously worked as a Principal at Novartis Pharmaceuticals Corp.
Mr. Bonaccorso completed his undergraduate degree at Fairleigh Dickinson University in 1985 and obtained an MBA from Kean University in 1993.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 132 392 ( 0.31% ) | 783 761 $ | 31-03-2024 |
Actieve functies van Joe Bonaccorso
| Bedrijven | Functie | Begin |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-02-2018 |
Eerdere bekende functies van Joe Bonaccorso
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Opleiding van Joe Bonaccorso
| Fairleigh Dickinson University | Undergraduate Degree |
| Kean University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
